D
Derek P. Chew
Researcher at Flinders University
Publications - 393
Citations - 21169
Derek P. Chew is an academic researcher from Flinders University. The author has contributed to research in topics: Myocardial infarction & Acute coronary syndrome. The author has an hindex of 60, co-authored 342 publications receiving 18879 citations. Previous affiliations of Derek P. Chew include Flinders Medical Centre & Auckland City Hospital.
Papers
More filters
Journal ArticleDOI
Balloon aortic valvuloplasty to bridge and triage patients in the era of trans‐catheter aortic valve implantation
TL;DR: To describe the use of balloon aortic valvuloplasty (BAV) as a method of selecting patients for definitive aortsic valve therapy, and to describe the importance of knowing which patients are suitable for BAV selection.
Journal Article
Update on Pharmacology for Restenosis.
TL;DR: Stent-based pharmacologic therapy to enhance local delivery of the drug has emerged as a promising anti-restenosis strategy.
Journal ArticleDOI
Assessment of early diastolic left ventricular function by two-dimensional echocardiographic speckle tracking
TL;DR: This non-invasive assessment of apical diastolic untwist is related to established echocardiographic measures of diastsolic function and may illustrate the importance of a ventricular suction effect in varying left ventricular filling states.
Journal ArticleDOI
Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention
Albert W. Chan,Martin J. Quinn,Deepak L. Bhatt,Derek P. Chew,David J. Moliterno,Eric J. Topol,Stephen G. Ellis +6 more
TL;DR: Within this large prospective registry, beta-blocker use was associated with a marked long-term survival benefit among patients undergoing successful elective percutaneous coronary revascularization.
Journal ArticleDOI
Initial experience with the balloon expandable Edwards-SAPIEN Transcatheter Heart Valve in Australia and New Zealand: the SOURCE ANZ registry: outcomes at 30 days and one year.
Darren L. Walters,Ajay Sinhal,David W. Baron,Sanjeevan Pasupati,S. Thambar,Gerald Yong,Nigel Jepson,Ravinay Bhindi,Jayme Bennetts,Robert Larbalestier,Andrew Clarke,Peter W. Brady,H. Wolfenden,A. James,A. El Gamel,Paul Jansz,Derek P. Chew +16 more
TL;DR: TAVI in the ANZ clinical environment has demonstrated excellent outcomes for both the TA and TF approaches in highly selected patients, consistent with those demonstrated in European, Canadian registries and the pivotal US clinical trials.